FindMyKOL
Clinical trialNCT06016634RecruitingPhase 2Interventional

Alendronate for Osteonecrosis in Adults With Sickle Cell Disease

SponsorUniversity of California, DavisEnrollment30Avascular NecrosisIschemic NecrosisOsteonecrosisSickle Cell AnemiaSickle Cell Disease
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

A prospective, single-arm, intervention study of oral alendronate in adults with sickle cell disease and osteonecrosis
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Uc Davis Comprehensive Cancer Center

    Sacramento, California, United States

    Oyebimpe O Adesina, MD, MS
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Alendronate
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
9 Mar 2026
Primary completion
30 Sept 2027
Completion
31 Dec 2027
Last update posted
16 Jul 2026
Registered enrollment
30
Registry id
NCT06016634
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.